Alan Ashworth, PhD, FRS serves as President of the UCSF Helen Diller Family Comprehensive Cancer Center and Senior Vice President for Cancer Services, UCSF Health.
> more about Dr. Ashworth
Dr. Ashworth also serves as Professor of Medicine in the Division of Hematology/Oncology, Department of Medicine and holds the E. Dixon Heise Distinguished Professorship in Oncology. As Director of the Cancer Center ORU, Ashworth has authority comparable to academic department chairs in the School of Medicine, and works with his department chair colleagues to organize and resource faculty recruitments. Ashworth spends 50% of his time devoted to the direction, planning, and development of the research activities of the HDFCCC. The remainder of his time is devoted to his responsibilities as Senior Vice President of Cancer Clinical Services in UCSF Health and the leadership of his research laboratory.
Eric Small, MD serves as Deputy Director and Chief Scientific Officer. Dr. Small is Leader of the Prostate Cancer Program and also serves as Chief of the Department of Medicine/Division of Hematology/Oncology, UCSF.
> more about Dr. Small
Dr. Small holds the Stanford W. Ascherman and Norman R. Ascherman Endowed Chair as well as the Doris and Donald Fisher Distinguished Professorship in Clinical Cancer Research. Dr. Small also serves as Interim Associate Director for Clinical Sciences
. His responsibilities in the HDFCCC as Deputy Director are to assist Dr. Ashworth in strategic planning for the Center, and to represent the Center both internally and externally in the absence of the Director. Dr. Small assists Dr. Ashworth in the integration of clinical, laboratory and population science across the center. In addition, he is responsible for the oversight of HDFCCC clinical research activities. Dr. Small chairs the Cancer Center Clinical Research Oversight Committee, which develops policy and procedures governing all clinical research in the HDFCCC. In his role as Interim Associate Director for Clinical Sciences, Small has responsibility for the integration of clinical research across all Research Programs within the Center and ensures all Research Programs include work focused on clinical science. He participates in the regular review of Research Programs, and works to facilitate opportunities to further integrate clinical sciences where possible. Lastly, Small works with administration, Program leaders, fellow senior leaders, and Shared Resource directors and managers to assess and implement the ways in which the HDFCCC can support clinical research, as well as promote related Shared Resource services within programs.
Robert A. Hiatt, MD, PhD, serves as Associate Director for Population Sciences. Dr. Hiatt is Leader of the Cancer Control Program, as well as Professor of Genetic and Cancer Epidemiology, UCSF. He also leads the San Francisco Cancer Initiative.
> more about Dr. Hiatt
In his role as Associate Director for Population Sciences, Dr. Hiatt has responsibility for the integration of population science-based research across all Research Programs within the HDFCCC. He ensures all Research Programs include work focused on population science—in particular, on issues relevant to the HDFCCC catchment area—and provides oversight for community outreach and engagement (COE) activities. Dr. Hiatt participates in regular reviews of Research Programs and COE activities, and works to facilitate opportunities to further integrate population sciences where possible. Hiatt works with administration, Program leaders, fellow senior leaders, and Shared Resource directors and managers to assess and implement the ways in which the HDFCCC can support population science-based research.
Zena Werb, PhD serves as Associate Director for Basic Sciences. Dr. Werb is also Professor and Vice-Chair of the Department of Anatomy, UCSF.
> more about Dr. Werb
In her role as Associate Director for Basic Sciences, Dr. Werb has responsibility for the integration of basic science across all Research Programs within the HDFCCC and ensures all research programs include basic science-focused work. She participates in the regular review of Research Programs, and ensures that they take opportunities to further integrate basic sciences where possible. Dr. Werb works with administration, Program leaders, fellow senior leaders, and Shared Resource directors and managers to assess and implement the ways in which the HDFCCC can support basic research, as well as promote related Shared Resource services within Programs.
Emily Bergsland, MD serves as Associate Director for Education. Dr. Bergsland is Professor of Clinical Medicine and holds the Ernest Rosenbaum, MD, Endowed Chair in Medical Oncology, UCSF.
> more about Dr. Bergsland
In her role as Associate Director for Education, Dr. Bergsland has responsibility for the integration of training and education of biomedical researchers and health care professionals, including members of underserved populations, into programmatic efforts and HDFCCC initiatives. She participates in the regular review of Research Programs, and ensures opportunities to further integrate educational opportunities are taken where possible. Dr. Bergsland works with administration, Program leaders, and fellow senior leaders to assess and implement the ways in which the HDFCCC can support the education of biomedical researchers and health care professionals, as well as promote the coordination of cancer-related educational activities across institutional educational programs.
Benjamin Braun, MD, PhD serves as Associate Director for Shared Resources. Dr. Braun is Associate Professor in Residence, Department of Pediatrics, UCSF and Director of the Laboratory for Cell Analysis Core at the UCSF Helen Diller Family Comprehensive Cancer Center.
> more about Dr. Braun
In his role as Associate Director for Shared Resources, Dr. Braun assists the Director, Deputy Director, and Associate Director for Administration in reviewing HDFCCC Shared Resources and ensuring that they provide access to technologies, services, and scientific consultation that enhance scientific interaction and productivity. He works with HDFCCC Administration to routinely survey membership on Shared Resource usage and needs, and works with Shared Resource directors and managers to review and improve business plans, consider strategic investments, address HDFCCC membership needs, and to promote Shared Resource services among membership.
Lawrence Fong, MD serves as Associate Director for Immunotherapy. Dr. Fong is also Leader of the Cancer Immunotherapy Program, Co-Leader of the Cancer Immunology Program, and holds the Efim Guzik Distinguished Professor in Cancer Biology, UCSF.
Pamela Munster, MD serves as Associate Director for Developmental Therapeutics. Dr. Munster is also Professor, Department of Medicine (Hematology/Oncology) UCSF; Director of the Early Phase Clinical Trials Unit, Leader of the Experimental Therapeutics Program, and Co-leader of the Center for BRCA Research at the UCSF Helen Diller Family Comprehensive Cancer Center.
Alan P. Venook, MD, serves as Shorenstein Associate Director for Program Development. Additionally Dr. Venook is Professor of Clinical Medicine in the Division of Hematology/Oncology in the Department of Medicine, and holds the Madden Family Distinguished Professorship in Medical Oncology and Translational Research, UCSF.
Kim Rhoads, MD, MS, MPH serves as Director, Office of Community Engagement.
Guiding the executive leadership's work are advisory groups, including an Institutional Advisory Board, External Advisory Board, and Community Advisory Board.
Kate Shumate, MPA, serves as Chief of Staff; Director, Administration and Planning.
> more about Kate Shumate
Ms. Shumate is responsible for the administration of scientific activities in the Cancer Center, encompassing strategic planning, organizational development and planning, financial and programmatic planning and management of the CCSG grant, and program support for research, education and training within the Center. She is the single point of contact with relevant UCSF organizations, including the Dean’s office and the Office of University Development and Alumni Relations, and represents the HDFCCC to external agencies, in particular the NCI and the Association of American Cancer Institutes.
As the Associate Director of Administration, Ms. Shumate is a member of the HDFCCC Senior Leadership Group, the Cancer Center Clinical Research Oversight Committee (CCCROC), and the HDFCCC Executive Leadership Group. She works with external and internal advisory committees to integrate recommendations and implement alternative approaches to strategic initiatives. She also works closely with the Offices of the Chancellor, School of Medicine Dean, and Chief Executive Officer of UCSF Health. Ms. Shumate is also involved in campus-wide efforts, as the Staff Chair of the UCSF Committee on LGBT Issues, and a member of the UCSF Council on Campus Climate, Culture, and Inclusion. Within the HDFCCC, she coordinates the efforts of the emerging interest group in Cancer in the LGBT community.
Thomas Cunningham, PhD, CCRP, serves as Director of Finance and Operations.
> more about Thomas Cunningham
As Director of Finance and Operations, Mr. Cunningham is responsible for the HDFCCC financial portfolio, and his team provides financial planning and analysis, accounting, purchasing and procurement, and post-award financial management.
Vicky Agnew, serves as Director of Integrated Marketing and Communications.
Laurel Bray-Hanin, MA, serves as Vice President and Chief Operating Officer of Cancer Services.
Miriam Rike, MA, serves as Vice President Finance, Cancer Services.
Laura E. Crocitto, MD, MHA serves as Vice President and Chief Medical Officer (CMO), Cancer Services.
The Clinical Cancer Governance Board, chaired by Alan Ashworth, PhD, FRS, comprises departmental chairs of clinical oncology programs at UCSF, as well as representatives from the UCSF Medical Center and School of Medicine.
> View Membership Roster
Programmatically, the Cancer Center's work is concentrated among highly multidisciplinary areas, each of which includes lab scientists, clinical investigators, epidemiologists, and providers of patient care. Collaboration across disciplines ensures that insights gained in the lab can move quickly and effectively to cancer patients' bedsides. More about the Cancer Center's program areas can be found in our Research section.